%0 Journal Article
%T 特立帕肽在老年性骨质疏松症中的研究进展<br>Advances in Teriparatide in Senile Osteoporosis
%A 张泽金
%A 黄家峥
%A 常腾
%A 黄永东
%A 肖甲宇
%A 甘学文
%A 熊鹰
%J Journal of Clinical Personalized Medicine
%P 273-278
%@ 2334-3443
%D 2025
%I Hans Publishing
%R 10.12677/jcpm.2025.42174
%X 特立帕肽(Teriparatide)作为一种骨形成促进药物&#65292;近年来在老年性骨质疏松症的治疗中展现了显著的疗效。本文综述了特立帕肽在老年性骨质疏松症中的应用现状&#65292;包括其作用机制、临床效果、安全性及未来研究方向&#65292;旨在为老年性骨质疏松症的治疗提供参考。<br>Teriparatide, as a bone formation promoting drug, has shown remarkable efficacy in the treatment of senile osteoporosis in recent years. This article summarizes the current application of Teriparatide in senile osteoporosis, including its mechanism of action, clinical effects, safety and future research direction, aiming to provide a reference for the treatment of senile osteoporosis.
%K 特立帕肽&#65292
%K 老年性骨质疏松症&#65292
%K 骨形成促进物&#65292
%K 临床疗效<br>Teriparatide
%K Senile Osteoporosis
%K Bone Formation Promoter
%K Clinical Effects
%U http://www.hanspub.org/journal/PaperInformation.aspx?PaperID=110473